Centogene NV
NASDAQ:CNTG
Centogene NV
EPS (Diluted)
Centogene NV
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
EPS (Diluted)
€3
|
CAGR 3-Years
300%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
EPS (Diluted)
-€12
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
EPS (Diluted)
-€1
|
CAGR 3-Years
35%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
EPS (Diluted)
€3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
15%
|
|
Formycon AG
XETRA:FYB
|
EPS (Diluted)
€4
|
CAGR 3-Years
N/A
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's EPS (Diluted)?
EPS (Diluted)
-1.2
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's EPS (Diluted) amounts to -1.2 EUR.
What is Centogene NV's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-33%
Over the last year, the EPS (Diluted) growth was 43%. The average annual EPS (Diluted) growth rates for Centogene NV have been -4% over the past three years , -33% over the past five years .